FdaApplication
ANDA 214618
Identifiers
- fda_app_no: ANDA214618
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | ANDA |
| approval_date | 2023-03-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LENALIDOMIDE | LENALIDOMIDE | 2.5MG | CAPSULE;ORAL |
1 product